Syntopix was spun-out of Leeds University in 2003 with the backing of IP Group. It is involved in developing treatments for antibiotic resistance and diseases of the skin. Syntopix joined Aim on 23 March 2006, when it raised £4m (£3.3m net) at 177p a share.
Sector: Health
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds